Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Hydrogel-extracellular vesicle engineering delivery system: a promising therapeutic strategy for wound healing

Gao F., Hu Z., Xu H., Yu Y., Gao S., Sun J.

Narrative Review on Diabetic Foot, Chronic Wound, Chronic Inflammation, published in J Nanobiotechnology (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
J Nanobiotechnology (2026)
Reported sample size
—
Source database
Europe PMC
PMID
41814281
PMCID
PMC13093987
DOI
10.1186/s12951-026-04236-1
Citations
1

Abstract (original English)

Chronic refractory wounds, such as diabetic foot ulcers, present significant clinical challenges due to a dysregulated healing microenvironment. Extracellular vesicles (EVs) have emerged as promising therapeutic agents owing to their pro-angiogenic, anti-inflammatory, and regenerative properties. However, their clinical translation is hampered by rapid clearance and instability at the wound site. Hydrogel-based delivery systems offer an effective strategy to overcome these limitations by providing a protective and tunable platform for sustained EVs release. This review systematically synthesizes contemporary advances in EVs hydrogel (EVH) systems for chronic wound therapy. We critically evaluate design strategies encompassing various hydrogel matrices (natural, synthetic, and smart responsive), engineering approaches for EVs modification, and controlled-release mechanisms that collectively enhance therapeutic efficacy. By integrating findings from preclinical studies across diverse wound models, we highlight the synergistic roles of EVH systems in promoting angiogenesis, modulating immune responses, and accelerating tissue regeneration. Furthermore, this review addresses key translational challenges, including scalable EVs production, standardization, biosafety, and regulatory pathways. Finally, we provide forward-looking perspectives on the clinical translation of next-generat

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsHumansHydrogelsDrug Delivery SystemsWound HealingNeovascularization, PhysiologicExtracellular Vesicles

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research